Table 3.
ESRD
| |||
---|---|---|---|
Parameter Description | Regression Coefficient | p-Value | Hazard Ratio |
Age at First Renal Biopsy | |||
Age 18–50 | ref. | ref. | |
Age<18 & Age>50 at First Renal Biopsy | −0.162 | 0.773 | 0.850 |
Gender | |||
Female | ref. | ref. | |
Male | 0.267 | 0.517 | 1.307 |
Race/Ethnicity | |||
White | ref. | ref. | |
Hispanic Ethnicity | 0.997 | 0.121 | 2.711 |
Black Race | 0.832 | 0.190 | 2.298 |
First Biopsy Histopathologic Classification | |||
Mesangial (II) | ref. | ref. | |
Membranous (V) | 0.869 | 0.294 | 2.385 |
Proliferative (III, IV, III+V, IV+V) | 1.339 | 0.070 | 3.815 |
Induction Therapy | |||
Other (AZA, CYA) | ref. | ref. | |
CYC | 0.777 | 0.466 | 2.174 |
MMF | 0.634 | 0.555 | 1.886 |
None or Unknown Induction Therapy | −0.196 | 0.867 | 0.822 |
Time Between First and Second Biopsies | |||
>5 Years | ref. | ref. | |
<1 Year | 2.614 | 0.0001 | 13.65 |
>1–5 Years | 1.530 | 0.0028 | 4.619 |
DEATH
| |||
---|---|---|---|
Parameter Description | Regression Coefficient | p-Value | Hazard Ratio |
Age at First Renal Biopsy | |||
Age 18–50 | ref. | ref. | |
Age<18 & Age>50 at First Renal Biopsy | 1.221 | 0.027 | 3.391 |
Gender | |||
Female | ref. | ref. | |
Male | 0.743 | 0.218 | 2.102 |
Race/Ethnicity | |||
White | ref. | ref. | |
Hispanic Ethnicity | 0.092 | 0.913 | 1.097 |
Black Race | 0.340 | 0.671 | 1.405 |
First Biopsy Histopathologic Classification | |||
Mesangial (II) | ref. | ref. | |
Membranous (V) | 0.343 | 0.699 | 1.409 |
Proliferative (III, IV, III+V, IV+V) | 0.042 | 0.958 | 1.043 |
Induction Therapy | |||
Other (AZA, CYA) | ref. | ref. | |
CYC | 1.053 | 0.383 | 2.866 |
MMF | 0.711 | 0.576 | 2.095 |
None or Unknown Induction Therapy | 1.847 | 0.143 | 6.340 |
Time Between First and Second Biopsies | |||
>5 Years | ref. | ref. | |
<1 Year | 2.825 | 0.002 | 16.860 |
>1–5 Years | 2.093 | 0.011 | 8.106 |